Harnessing Nanoparticles for Immunomodulation and Vaccines
about
Effects of engineered nanoparticles on the innate immune system.Pregnancy and infection: using disease pathogenesis to inform vaccine strategy.Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display VaccinationThe Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
P2860
Q47685899-9747BDFA-07A4-4AA6-98B1-A3F35818E198Q48504993-1A195F2C-3620-4360-858C-5060BAF74719Q50420436-745C706A-7206-459C-8432-DC038755B322Q55364687-A2E5AACE-98F5-4DE2-9E0D-1A2653141570Q55668744-A27333D1-403C-47C0-A833-2DAF9D636C98Q56355788-8620931B-DA95-4CDC-A20F-C15E73F4A747Q58803479-D0650783-23F4-4210-9AFE-4672F6824D18
P2860
Harnessing Nanoparticles for Immunomodulation and Vaccines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Harnessing Nanoparticles for Immunomodulation and Vaccines
@en
Harnessing Nanoparticles for Immunomodulation and Vaccines.
@nl
type
label
Harnessing Nanoparticles for Immunomodulation and Vaccines
@en
Harnessing Nanoparticles for Immunomodulation and Vaccines.
@nl
prefLabel
Harnessing Nanoparticles for Immunomodulation and Vaccines
@en
Harnessing Nanoparticles for Immunomodulation and Vaccines.
@nl
P2093
P2860
P356
P1433
P1476
Harnessing Nanoparticles for Immunomodulation and Vaccines
@en
P2093
Ariane C Gomes
Martin F Bachmann
Mona Mohsen
P2860
P356
10.3390/VACCINES5010006
P577
2017-02-14T00:00:00Z